1. Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors

   • Marc Evans
   • Angharad R. Morgan
   • Stephen C. Bain

   Current Opinion 23 June 2021 Pages: 1243 - 1255

   

2. Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients

   • Lucien Roulet
   • Victoria Rollason
   • Valérie Piguet

   Review Article Open access 01 July 2021 Pages: 1257 - 1272

   

3. Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations

   • Markku Lähteenvuo
   • Jari Tiihonen

   Review Article Open access 01 July 2021 Pages: 1273 - 1284

   

4. Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists

   • Jeffrey Gilreath
   • Mimi Lo
   • Joseph Bubalo

   Review Article Open access 23 June 2021 Pages: 1285 - 1305

5. Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review

   • Marc-Alexandre Duceppe
   • Salmaan Kanji
   • David R. Williamson

   Systematic Review 05 July 2021 Pages: 1307 - 1329

   

6. Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

   • Matt Shirley

   Adis Drug Evaluation Open access 22 July 2021 Pages: 1331 - 1342

7. Pamiparib: First Approval

   • Anthony Markham

   AdisInsight Report 21 July 2021 Pages: 1343 - 1348

   

8. Amivantamab: First Approval

   • Yahiya Y. Syed

   AdisInsight Report 22 July 2021 Pages: 1349 - 1353

   

9. Infigratinib: First Approval

   • Connie Kang

   AdisInsight Report Open access 19 July 2021 Pages: 1355 - 1360

   

10. Correction to: Fostamatinib: A Review in Chronic Immune Thrombocytopenia

    • Julia Paik

    Correction 26 May 2021 Pages: 1361 - 1361

11. Correction to: Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome

    • Yahiya Y. Syed

    Correction Open access 10 July 2021 Pages: 1363 - 1364